Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals

@article{vanSighem2010LifeEO,
  title={Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals},
  author={Ard van Sighem and Luuk Gras and Peter Reiss and Kees Brinkman and Frank de Wolf},
  journal={AIDS},
  year={2010},
  volume={24},
  pages={1527–1535}
}
Objective:To compare life expectancies between recently diagnosed HIV-infected patients and age and sex-matched uninfected individuals from the general population. Design:National observational HIV cohort in the Netherlands. Methods:Four thousand, six hundred and twelve patients diagnosed with HIV between 1998 and 2007 and still antiretroviral therapy-naive as of 24 weeks after diagnosis were selected. Progression to death compared to the age and sex-matched general population was studied with… 
Life expectancy and disparities in survival among HIV-infected people receiving antiretroviral therapy: an observational cohort study in Kathmandu, Nepal
TLDR
There are disparities in survival among HIV-infected people in Nepal and evidence is offered of the benefits of enrolling early in care in general and ART in particular, and the survival payback of ART is proven.
Long-Term Survival in HIV Positive Patients with up to 15 Years of Antiretroviral Therapy
TLDR
Observed mortality remained fairly constant by duration of cART and was modelled accurately by accepted prognostic factors, and changes in mortality with age were similar to those in the Australian general population.
Life Expectancy in the Immune Recovery Era: The Evolving Scenario of the HIV Epidemic in Northern Italy
TLDR
An increasing gradient of LE exists between nIR, post-HAART, and IR groups, with the latter, above the age of 40 years only, reaching LE of general population, with an approximately 5-year gap in LE observed in IR patients.
Life expectancy of HIV-infected patients followed at the largest hospital in Guinea-Bissau is one-fourth of life expectancy of the background population
TLDR
LE was shown to be markedly lower among HIV-infected patients compared with the background population, and no improvement in prognosis in Bissau was observed over time.
Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study
TLDR
Life expectancy in people treated for HIV infection has increased by over 15 years during 1996-2008, but is still about 13 years less than that of the UK population.
Decreasing Excess Mortality of HIV-Infected Patients Initiating Antiretroviral Therapy: Comparison with Mortality in General Population in China, 2003–2009
TLDR
Substantial decreases in excess mortality were observed from 2003 to 2009 in China among HIV-infected patients receiving free cART, however, mortality amongAIDS patients remained higher than the general Chinese population.
Characteristics and Outcome of Patients Diagnosed With HIV at Older Age
TLDR
One-fifth of HIV patients are diagnosed at older age (≥50 years) and those older patients have less favorable outcome compared with the younger patients, pointing to the need of educational and screening programs within older populations and for a closer follow-up of older HIV patients.
Lower mortality and earlier start of combination antiretroviral therapy in patients tested repeatedly for HIV than in those with a positive first test
TLDR
Frequent repeated testing for HIV may improve the rate of timely diagnosis and treatment, thereby preventing disease progression.
LIFE EXPECTANCIES OF HIV-POSITIVE ADULTS RECEIVING ANTIRETROVIRAL TREATMENT IN SOUTH AFRICA
TLDR
Life expectancies of patients receiving ART in South Africa are estimated using data from a collaboration of eight South African ART programmes operating mainly in the public health sector, with those in patients starting ART at higher CD4 counts coming close to the corresponding life expectancies in HIV-negative adults.
Assessment of patients with late diagnosis and missed opportunities in the Swedish HIV-1 epidemic
TLDR
Assessment of the extent of late diagnosis of HIV-1 infection in Sweden shows a high proportion of patients diagnosed late, but also emphasizes that there are several opportunities to improve this.
...
...

References

SHOWING 1-10 OF 34 REFERENCES
Mortality and progression to AIDS after starting highly active antiretroviral therapy
TLDR
Survival probabilities were high among HIV-infected patients initiating HAART at an early stage of infection, and the best therapy strategy is therefore to startHAART at this stage of infections, however, deferring HAART in patients with high CD4 cell counts may be clinically more appropriate given toxicity and adherence problems.
Survival of Persons with and without HIV Infection in Denmark, 19952005
TLDR
This study estimates median survival and age-specific mortality rates for an entire HIV-infected population compared with a cohort from the general population in Denmark, with continuous enrollment of both newly diagnosed residents and immigrants with existing HIV infection.
Estimating the proportion of patients infected with HIV who will die of comorbid diseases.
Mortality in Patients With Successful Initial Response to Highly Active Antiretroviral Therapy Is Still Higher Than in Non-HIV-Infected Individuals
TLDR
Mortality in HIV-infected patients with a good initial response to HAART is still higher than in the general population, despite the introduction of highly active antiretroviral therapy.
Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy
TLDR
A significant and progressive decrease in mortality and increase in life expectancy were observed over the 12-year study period and were directly associated with the use of modern forms of HAART.
Low mortality in HIV-infected patients starting highly active antiretroviral therapy: a comparison with the general population
TLDR
HIV-infected patients starting highly active antiretroviral therapy (HAART) with a CD4 cell count above 200 × 106 cells/l had low mortality rates that were comparable with the rates found in other chronic medical diseases.
Improved survival in HIV-infected persons: consequences and perspectives.
TLDR
Despite the improvements in antiretroviral therapy, there is still an excess mortality among HIV patients, which appears to be only partially attributable to immunodeficiency, with lifestyle factors potentially playing a pronounced role, so an effort to further increase survival must target risk factors for both HIV-related and -unrelated mortality.
...
...